Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
Report an inappropriate content
Please select one of the options below.
  • Length
    AllShort (less than 5 minutes)Medium (5-20 minutes)Long (more than 20 minutes)
  • Date
    AllPast 24 hoursPast weekPast monthPast year
  • Resolution
    AllLower than 360p360p or higher480p or higher720p or higher1080p or higher
  • Source
    All
    Dailymotion
    Vimeo
    Metacafe
    Hulu
    VEVO
    Myspace
    MTV
    CBS
    Fox
    CNN
    MSN
  • Price
    AllFreePaid
  • Clear filters
  • SafeSearch:
  • Moderate
    StrictModerate (default)Off
Filter
[STO Spotlight] Unedited Stephanie Graff on Adjuvant WIDER: Ph3b of ribociclib+HR in HR+/HER2- BC
6:47
[STO Spotlight] Unedited Stephanie Graff on Adjuvant WIDER: Ph3b o…
755 views4 days ago
YouTubeP2PMD
(7~8월 호전사례 2)유방암 폐전이, 호전되는 방법은?
8:08
(7~8월 호전사례 2)유방암 폐전이, 호전되는 방법은?
248 views5 days ago
YouTube조병식 TV
삼중음성유방암 30대 여성도 위험! 반드시 알아야 할 치료 방법 ☑️
6:59
삼중음성유방암 30대 여성도 위험! 반드시 알아야 할 치료 방법 ☑️
3.4K views1 day ago
YouTube닥터BTS
OS Therapies (NYSE: OSTX) announced that it will provide stakeholders with a detailed update on Tuesday, September 2, 2025, regarding the company’s End of Phase 2 meeting with the FDA. The meeting discussed the regulatory path forward for OST-HER2 in recurrent, fully resected, pulmonary metastatic osteosarcoma. OS Therapies is a B2i Digital Featured Company. View their comprehensive profile at https://b2idigital.com/os-therapies-1. OST-HER2 is an immunotherapy that leverages Listeria bacteria to
OS Therapies (NYSE: OSTX) announced that it will provide stak…
251 views1 day ago
FacebookB2i Digital
See more videos
Static thumbnail place holder
More like this
Feedback
  • Privacy
  • Terms